ACR Convergence 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences
Food and Drug Administration at ACR Convergence 2026
Nov 6–11, 2026 Orlando, FL ~15k attendees Website
Food and Drug Administration brings 5 presentations to ACR Convergence 2026 in Orlando. Its program covers new rheumatology approvals, safety issues identified in adult care over the past year and regulatory questions around cellular therapy, along with a review of an FDA conference on pediatric lupus.
| Organization | ACR Convergence 2026 Attendance |
|---|---|
Food and Drug Administration Silver Spring, MD | |
U.S. federal agency responsible for regulating food, drugs, biologics, and medical devices. | Session Sun Nov 8 3:30pm–5:00pm 2026 Rheumatology Update from the FDA
Talk Sun Nov 8 3:30pm–3:55pm New Approvals in Rheumatology; An Exciting Year. Talk Sun Nov 8 3:55pm–4:20pm Review of Recent FDA Conference on Pediatric SLE Talk Sun Nov 8 4:20pm–4:45pm New Safety Issues Identified in the Last Year in Adult Rheumatology Talk Mon Nov 9 1:20pm–1:40pm Regulatory Issues and Cellular Therapy: FDA Overview |
Find decision makers at Food and Drug Administration
Tell us what you sell and we’ll find the people at Food and Drug Administration most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American College of Rheumatology (ACR). Organization details are derived from the ACR’s published program and exhibitor floor plan, and each organization’s own website. Submit a correction